Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

AcelRx Pharmaceuticals Inc

+ Add to Watchlist

ACRX:US

3.4800 USD 0.0500 1.46%

As of 16:00:00 ET on 05/27/2015.

Snapshot for AcelRx Pharmaceuticals Inc (ACRX)

Open: 3.4500 Day's Range: 3.3900 - 3.5000 Volume: 218,473
Previous Close: 3.4300 52wk Range: 2.9600 - 11.6500 1-Yr Rtn: -63.85%

Stock Chart for ACRX

No chart data available.
  • ACRX:US 3.4900
  • 1D
  • 1M
  • 1Y
3.4300
Interactive ACRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.9490
Est. EPS (USD) (12/2015) -0.7980
Est. PEG Ratio -
Market Cap (M USD) 153.40
Shares Outstanding (M) 44.34
30 Day Average Volume 707,173
Price/Book (mrq) 3.7607
Price/Sale (ttm) 28.5814
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/11/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ACRX

AcelRx Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of acute and breakthrough pain. The Company's solutions are designed to provide mild sedation, anxiety reduction and pain relief for patients undergoing painful procedures in a physician's office.

Howard B Rosen "Howie"Interim CEOTimothy E Morris "Tim"Chief Financial Officer
Pamela P PalmerChief Medical Officer/Co-FounderLawrence G HamelChief Development Officer
More Company Profile & Key Executives for ACRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil